{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-015066","form_type":"8-K","ticker":"BLFS","cik":"0000834365","company_name":"BIOLIFE SOLUTIONS INC","filed_at":"2022-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:03.886677+00:00","generated_at":"2026-06-25T01:46:52.452213+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"confidence":"high","headline":"BioLife Solutions stockholders re-elect all directors, approve equity plan increase","bullets":["All five nominees re-elected: Michael Rice (26.8M for), Joydeep Goswami (26.5M), Joseph Schick (21.9M), Amy DuRoss (26.0M), Rachel Ellingson (26.3M).","Non-binding advisory vote on executive compensation approved with 20.1M for, 7.0M against, 127K abstain.","Ratification of Grant Thornton as independent auditor for FY2022 passed (31.1M for, 10K against, 8K abstain).","Amendment to 2013 Performance Incentive Plan to increase authorized shares by 2M to 8.5M approved (19.1M for, 8.0M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-015066","json":"https://secwatch.observer/filing/0001437749-22-015066.json","markdown":"https://secwatch.observer/filing/0001437749-22-015066.md","text":"https://secwatch.observer/filing/0001437749-22-015066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/834365/000143774922015066/0001437749-22-015066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/834365/000143774922015066/bioli20220614_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:46:52.452213+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}